AMEX:LABU   Direxion Daily S&P Biotech Bull 3X Shares
got out of LABD to buy LABU on next pullback down to about $88.40 earnings growth and M&A optimism to reestablish in biotech/ healthcare. watching that ceiling of resistance to potentially pull profits

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。